Chikungunya vaccine safety in pregnancy under review
NCT ID NCT07414524
First seen Feb 24, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study looks at the safety of a chikungunya vaccine (VLA1553) given to pregnant women in Brazil. Researchers will track pregnancy and baby health outcomes for up to 12 weeks after birth in 200 vaccinated women and compare them to a similar group of pregnant women who received routine vaccines. The goal is to see if the vaccine causes any problems during pregnancy or for the baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.